Zurück zu Projekte

18543.1 PFLS-LS

Allosteric modulators of TrkB, a neuroprotective receptor: advancing compounds towards clinical candidate phase

Zusammenfassung

Allosteric modulators of TrkB, a neuroprotective receptor: advancing compounds towards clinical candidate phase

Weitere Texte

Abstract

Addex has identified novel small molecules, which are positive allosteric modulators of the neuroprotective receptor TrkB. These compounds, which have a major potential for the treatment of neurodegenerative diseases (e.g. Huntington¿s disease and amyotrophic lateral sclerosis) will be profiled in unique assays developed by the Krause group at University of Geneva. The results obtained will enable the prioritization of compounds for later stages of preclinical development.

Beteiligte

Tim Dyer

Wirtschaftspartner

Tim.Dyer@addexpharma.com

Addex Pharmaceuticals SA Tim Dyer Chemin des Aulx 12 1228 Plan-les-Ouates GE CH

Karl-Heinz Krause

Kontaktperson

karl-heinz.krause@unige.ch

Université de Genève Karl-Heinz Krause Rue Michel Servet 1 1211 Genève GE CH

Projektdetails

Forschungsstelle
INNOSUISSE
Projektstatus
Abgeschlossen
Projekttyp
Forschungsprojekt
Startdatum
2016-12-31
Enddatum
2019-03-31
Bewilligte Gesamtkosten
CHF 440762.00
Sektion
20 Förderbereich Life Sciences
NABS Politikbereich
Industrielle Produktivität und Technologie

Forschungsdisziplinen

  • T490 Biotechnology 100.0%